These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Author: Liu PY, Wu PC, Chen CY, Chen YC.
    Journal: Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143.
    Abstract:
    We present the case of a woman with paranoid schizophrenia who was receiving oral risperidone. She developed neuroleptic malignant syndrome (NMS) following the addition of depot fluphenazine for the treatment of refractory delusions. NMS subsided and psychotic features were controlled after both antipsychotics were discontinued and the patient was treated instead with olanzapine.
    [Abstract] [Full Text] [Related] [New Search]